Lynette Rogers to Biomarkers
This is a "connection" page, showing publications Lynette Rogers has written about Biomarkers.
Connection Strength
0.583
-
Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder. J Autism Dev Disord. 2022 Dec; 52(12):5342-5355.
Score: 0.147
-
MiR-29b is associated with perinatal inflammation in extremely preterm infants. Pediatr Res. 2021 03; 89(4):889-893.
Score: 0.131
-
Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation. Mol Cancer Ther. 2016 09; 15(9):2220-31.
Score: 0.101
-
Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants. PLoS One. 2013; 8(12):e82537.
Score: 0.084
-
Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates. Pediatr Pulmonol. 2021 12; 56(12):3847-3856.
Score: 0.036
-
Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial. JAMA Pediatr. 2018 12 01; 172(12):1126-1134.
Score: 0.030
-
PEG 3350 Administration Is Not Associated with Sustained Elevation of Glycol Levels. J Pediatr. 2018 04; 195:148-153.e1.
Score: 0.028
-
Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. Eur J Pediatr. 2011 Jul; 170(7):859-63.
Score: 0.017
-
CoASH and CoASSG levels in lungs of hyperoxic rats as potential biomarkers of intramitochondrial oxidant stresses. Pediatr Res. 2002 Mar; 51(3):346-53.
Score: 0.009